# Inhaled Versus Intravenous Milrinone for Patients Undergoing Mitral Valve Replacement Surgery

> **NCT05838846** · PHASE2,PHASE3 · COMPLETED · sponsor: **Menoufia University** · enrollment: 60 (actual)

## Conditions studied

- Mitral Valve Replacement
- Pulmonary Hypertension
- Inhaled Milrinone
- Intravenous Milrinone

## Interventions

- **DRUG:** Inhaled Milrinone
- **DRUG:** IV Milrinone

## Key facts

- **NCT ID:** NCT05838846
- **Lead sponsor:** Menoufia University
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-04-01
- **Primary completion:** 2025-01-01
- **Final completion:** 2025-01-01
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2025-02-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05838846

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05838846, "Inhaled Versus Intravenous Milrinone for Patients Undergoing Mitral Valve Replacement Surgery". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05838846. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*